Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00782691|
Recruitment Status : Unknown
Verified October 2008 by Radboud University.
Recruitment status was: Recruiting
First Posted : October 31, 2008
Last Update Posted : October 31, 2008
|Condition or disease||Intervention/treatment|
|Head and Neck Cancer||Other: CT-FDG/PET scan of the head-and-neck region|
|Study Type :||Observational|
|Estimated Enrollment :||15 participants|
|Official Title:||Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.|
|Study Start Date :||July 2008|
|Estimated Primary Completion Date :||December 2009|
Head-and-neck cancer patients.
Head-and-neck cancer patients eligible for therapeutic lymph node dissection of cervical nodes.
Other: CT-FDG/PET scan of the head-and-neck region
CT-FDG/PET scan of the head-and-neck region
- How accurate are the various FDG-PET segmentation tools? [ Time Frame: Measurements are performed in conjunction with the clinical pathologist directly postoperatively. ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00782691
|Contact: Dominic A.X. Schinagl, MD||NL24email@example.com|
|Radboud University Nijmegen Medical Centre||Recruiting|
|Nijmegen, Gelderland, Netherlands, 6500HB|
|Principal Investigator: Dominic AX Schinagl, MD|